Literature DB >> 26196180

Rabies Postexposure Prophylaxis for Travelers Injured by Nonhuman Primates, Marseille, France, 2001-2014.

Agathe Blaise, Philippe Parola, Philippe Brouqui, Philippe Gautret.   

Abstract

Most exposures of residents of Marseille to nonhuman primates occurred among unvaccinated adult travelers to Southeast Asia within the first 10 days of their arrival at 2 major tourist locations in Thailand and 1 in Indonesia. A small proportion of travelers received rabies immunoglobulin in the country of exposure.

Entities:  

Keywords:  France; Rabies; nonhuman primates; rabies postexposure prophylaxis; viruses

Mesh:

Substances:

Year:  2015        PMID: 26196180      PMCID: PMC4517731          DOI: 10.3201/eid2108.150346

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Rabies is estimated to cause >60,000 human deaths worldwide annually on the basis of a probability decision-tree approach; primarily resulting from dog bites, the disease is of public health concern in most countries in Asia and Africa (). Nonhuman primates (NHPs) are not primary reservoirs of rabies; nevertheless, 159 reports of rabies in NHPs, of which 134 were laboratory-confirmed cases, have been retrieved from various sources in South America, Africa, and Asia (). This total is probably underestimated because weak rules pertaining to rabies surveillance in some countries, such as not requiring reports of rabidity in all species, are likely to result in underreporting of rabid NHPs. Cases of rabies in humans after injury by NHPs were also reported in 25 persons, mostly in Brazil (). Although rarely reported, documented cases of rabies infections in NHPs and subsequent transmission to humans do occur, warranting the need for rabies postexposure prophylaxis (PEP) after NHP exposure in countries to which rabies is endemic. The epidemiology of NHP-related injuries has been described in case reports or small cohorts of patients only (,). Here, we describe the epidemiology of 135 cases of NHP-related injuries in persons seen in the Marseille Rabies Treatment Centre in Marseille, France.

The Study

During 2001–2014, epidemiologic data on NHP–related injuries and associated rabies PEP treatment were prospectively collected for patients of the Marseille Rabies Treatment Centre. Demographics, place of exposure, travel characteristics, clinical data, and rabies PEP were documented. A total of 135 cases of persons injured by NHPs reported during a 14-year period were included, representing an average 10 cases/year (range 4–16 cases/year), with a tendency to increase over time (Figure, panel A). Exposures were more frequently reported during July–October (Figure, panel B). The F/M sex ratio of patients was 1.1, and the mean age was 30 years (median 27 years; range 3–70 years); 20.7% of patients were <15 years of age (Table 1). Of the 135 patients, 2 had complete and 1 incomplete preexposure vaccination against rabies. Most exposures (n = 120, 88.9%) occurred outside of France, notably in Southeast Asia (n = 82); most cases occurred in Thailand (n = 48) and Indonesia (n = 25). Most exposures in Thailand were on Monkey Beach on Koh Phi Phi Island and in the Lopburi Monkey Temple; most exposures in Indonesia were in the Ubud Monkey Forest in Bali (Table 2). Most persons injured abroad were tourists with a mean travel duration of 21 days (median 17 days; range 3–180 days). The mean time between the first date of travel and exposure was 10 days (median 8 days; range 1–50 days).
Figure

Number of injuries to humans by nonhuman primates requiring rabies postexposure prophylaxis, Marseille Rabies Treatment Centre, Marseille, France, 2001–2014. A) Logarithmic regression was used to calculate a line of best fit of y = 2,3191ln(x) + 5.4699 (black line). B) Cumulative occurrence by month.

Table 1

Demographic, vaccination status, place of exposure, and travel characteristics of 135 persons injured by nonhuman primates requiring rabies postexposure prophylaxis, Marseilles, France, 2001–2014

CharacteristicsNo. (%)
Female sex70 (51.9)
Age group, years
0–1528 (20.7)
16–3971 (52.6)
40–5927 (20.0)
60 and over9 (6.7)
Preexposure vaccination against rabies2 (1.5)
Place of exposure
France15 (11.1)
Thailand48 (35.7)
Indonesia25 (18.5)
Other countries in Asia*14 (10.4)
North Africa†13 (9.6)
Sub-Saharan Africa‡11 (8.1)
Central and South America and Caribbean§6 (4.4)
Spain/Rock of Gibraltar3 (2.2)
Reason for travel, n = 120
Tourism99 (82.5)
Other¶6 (5.0)
Not documented15 (12.5)
Days of travel duration, n = 119#
0–76 (5.0)
8–1421(17.6)
15–2143 (36.2)
21–2819 (16.0)
>2914 (11.8)
Not documented16 (13.4)
Days between first date of travel and exposure, n = 119#
0–741 (34.5)
8–1433 (27.6)
15–2117 (14.3)
>22 d4 (3.4)
Not documented24 (20.2)

*Vietnam (5), India (4) Cambodia (3), Myanmar (1), Sri-Lanka (1).
†Morocco (10), Algeria (3).
‡Madagascar (4), Kenya (4), Botswana (1), Cameroon (1), Central African Republic (1).
§Brazil (2), Anguilla (1), Dominican Republic (1), Mexico (1), Peru (1).
¶Persons, or their descendants, who have immigrated to Marseille from another country who were exposed while visiting friends and relatives in their country of origin (3), expatriate (1), humanitarian worker (1), and student (1).
#Expatriate traveler was excluded.

Table 2

Detailed place of exposure of 73 travelers injured by nonhuman primates in Thailand and Indonesia requiring rabies postexposure prophylaxis, Marseille, France, 2001–2014

Location
No.
Thailand, total48
Koh Phi Phi
Monkey Beach15
Lopburi
Lopburi Monkey Temple8
Bangkok
Park2
Zoo1
Temple1
Koh Samui
Monkey show2
Koh Phangan
Undocumented2
Phuket
Patong Beach2
Other
Temple, Chiang Mai1
Street, Korat1
Temple, Singburi1
Temple, Sukhothai1
Not documented11
Indonesia, total49
Bali24
Ubud sacred monkey forest sanctuary17
Temple, Uluwatu 2
Temple, undocumented2
Undocumented3
Not documented1
Number of injuries to humans by nonhuman primates requiring rabies postexposure prophylaxis, Marseille Rabies Treatment Centre, Marseille, France, 2001–2014. A) Logarithmic regression was used to calculate a line of best fit of y = 2,3191ln(x) + 5.4699 (black line). B) Cumulative occurrence by month. *Vietnam (5), India (4) Cambodia (3), Myanmar (1), Sri-Lanka (1).
†Morocco (10), Algeria (3).
‡Madagascar (4), Kenya (4), Botswana (1), Cameroon (1), Central African Republic (1).
§Brazil (2), Anguilla (1), Dominican Republic (1), Mexico (1), Peru (1).
¶Persons, or their descendants, who have immigrated to Marseille from another country who were exposed while visiting friends and relatives in their country of origin (3), expatriate (1), humanitarian worker (1), and student (1).
#Expatriate traveler was excluded. Injuries most commonly occurred on the upper limbs (57.8%); subsequent occurrences of injury were on lower limbs (28.9%), head (5.9%), trunk (3.7%), or multiple sites (2.2%). Details of 2 cases were not documented. Most injuries (66.7%) were severe transdermal type 3 injuries according to the WHO classification, resulting from severe bites (); the remaining (33.3%) were type 2 injuries (minor abrasions and scratches without bleeding). According to WHO guidelines (), rabies immune globulin (RIG) was indicated for 65.2% of patients who had type 3 injuries and no previous vaccination against rabies. Among patients injured abroad, 58 (48.3%) started rabies PEP abroad; the mean time between injury and treatment was 1 day (median 0 days; range 0–21 days). Most (77.6%) underwent the Essen protocol and 17.2% underwent the Zagreb protocol (); and 5.2% underwent the 7-dose mouse brain vaccine protocol (local subcutaneous and intradermal protocol used in North Africa: seven 1.0-mL subcutaneous injections from day 0 through day 6, followed by 2-site 0.1-mL intradermal injections on days 10, 14, 29, and 90). A total of 35 patients (25.9%) had an indication for RIG, of whom 8 (22.9%) received the RIG abroad. Among the 27 remaining patients, the mean time between first injection of vaccine abroad and the first consultation in France was 12 days (median 12 days; range 3–31 days). An additional 6 patients (17.1%) received RIG in France, and the remaining 21 patients (60.0%) did not. Of those 21 patients, 20 sought follow-up medical consultation in France >7 days after the first vaccine was provided abroad; the initiation of RIG is contraindicated if >7 days have passed since vaccine initiation (). A total of 62 patients started their treatment in France with a mean time between injury and treatment of 15 days (median 11 days; range 2–123 days). Most underwent the Essen protocol (71.0%), followed by the Zagreb protocol (27.4%). One patient who received complete preventive vaccination received 2 booster doses at days 0 and 3. Of 44 patients for whom RIG was indicated, 39 (88.6%) received RIG. No cases of rabies were observed among the 135 persons injured by NHPs.

Conclusions

NHP bites among travelers are not infrequent. An estimated 31% of injuries requiring rabies PEP among international travelers are caused by NHPs, which rank second after dogs in most studies and first in studies conducted among travelers returning from Southeast Asia (). In a recent GeoSentinel survey involving 2,697 travelers requiring rabies PEP, NHPs accounted for 66% of animal bites occurring in Southeast Asia, and tourists made up a disproportionately large portion of the NHP exposures (92%) (). Bites by NHPs can transmit other potentially life-threatening zoonoses, such as the herpes B virus (Cercopithecine herpesvirus 1). The human herpes B virus infections that have been described have all occurred after contact with macaques in a biomedical research setting (). However, samples of >80% of macaques at the Monkey Forest in Bali tested positive for antibodies against the herpes B virus, a naturally occurring infectious agent that is endemic among macaque monkeys from Asia (). Appropriate B virus prophylaxis may be considered for travelers injured by Asian macaques, although this treatment is not applicable to those injured by New World NHPs (,). In this study, we observed that most exposures occurred among adult tourists to Southeast Asia during the summer months, which probably reflects travel volume. Furthermore, we identified 2 major tourist destinations in Thailand and 1 in Indonesia as locations where monkeys were most likely to bite tourists, reflecting the regional distribution of both monkey and tourist populations. Most patients were taking relatively short trips and were bitten within the first 10 days after their arrival. Indeed, monkey bites are relatively frequent at these tourist places. An estimated 6% of visitors to Bali monkey temples are bitten by macaque monkeys (). No detailed information is available about documented cases of rabies among monkeys at these tourist destinations; however, confirmed cases have been reported in monkeys as well as in gibbons and langurs in Thailand (Panichabhongse P., The epidemiology of rabies in Thailand [thesis]. 2001 [cited 2015 Jun 1] (http://mro.massey.ac.nz/bitstream/handle/10179/4545/02_whole.pdf?sequence=1&isAllowed=y). We show that most of the cases involved persons who had not received preexposure immunization and that ≈33% of patients for whom RIG was indicated did not receive RIG. Only a small proportion of travelers received RIG in the country of exposure, which reflects the limited supply of this biological agent in many countries. Unvaccinated Western travelers who are unaware of the risk for rabies regularly engage in contact with animals during their trips, often resulting in expensive PEP. To decrease the need for rabies PEP after animal bites, it is crucial that travelers to countries in which rabies is endemic be fully informed of this specific risk, which can be easily minimized by avoiding contact with animals, avoiding feeding them, avoiding smiling at them (showing teeth is a sign of aggression), avoiding dropping something that a monkey has grabbed, and avoiding showing fear. Our findings indicate that tourists should be given strong warnings before travel to visit Koh Phi Phi, Lopburi, or Ubud.
  9 in total

1.  Risk assessment: A model for predicting cross-species transmission of simian foamy virus from macaques (M. fascicularis) to humans at a monkey temple in Bali, Indonesia.

Authors:  Gregory Engel; Laura L Hungerford; Lisa Jones-Engel; Dominic Travis; Richard Eberle; Agustin Fuentes; Richard Grant; Randall Kyes; Michael Schillaci
Journal:  Am J Primatol       Date:  2006-09       Impact factor: 2.371

2.  B-virus (Cercopithecine herpesvirus 1) infection in humans and macaques: potential for zoonotic disease.

Authors:  Jennifer L Huff; Peter A Barry
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

3.  WHO Expert Consultation on Rabies. Second report.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2013

4.  Monkey bites in travelers: should we think of herpes B virus?

Authors:  Nicole Ritz; Nigel Curtis; Jim Buttery; Franz E Babl
Journal:  Pediatr Emerg Care       Date:  2009-08       Impact factor: 1.454

5.  What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously?

Authors:  P Khawplod; H Wilde; P Chomchey; M Benjavongkulchai; W Yenmuang; N Chaiyabutr; V Sitprija
Journal:  Vaccine       Date:  1996-04       Impact factor: 3.641

6.  Animal-associated exposure to rabies virus among travelers, 1997-2012.

Authors:  Philippe Gautret; Kira Harvey; Prativa Pandey; Poh Lian Lim; Karin Leder; Watcharapong Piyaphanee; Marc Shaw; Susan C McDonald; Eli Schwartz; Douglas H Esposito; Philippe Parola
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

7.  Human exposure to herpesvirus B-seropositive macaques, Bali, Indonesia.

Authors:  Gregory A Engel; Lisa Jones-Engel; Michael A Schillaci; Komang Gde Suaryana; Artha Putra; Agustin Fuentes; Richard Henkel
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

Review 8.  Rabies in nonhuman primates and potential for transmission to humans: a literature review and examination of selected French national data.

Authors:  Philippe Gautret; Jesse Blanton; Laurent Dacheux; Florence Ribadeau-Dumas; Philippe Brouqui; Philippe Parola; Douglas H Esposito; Hervé Bourhy
Journal:  PLoS Negl Trop Dis       Date:  2014-05-15

9.  Monkey bites among U.S. military members, Afghanistan, 2011.

Authors:  Gregory A Engel; Agustin Fuentes; Benjamin P Y-H Lee; Michael A Schillaci; Lisa Jones-Engel
Journal:  Emerg Infect Dis       Date:  2013-04       Impact factor: 6.883

  9 in total
  4 in total

1.  Travel-related infections presenting in Europe: A 20-year analysis of EuroTravNet surveillance data.

Authors:  Martin P Grobusch; Leisa Weld; Abraham Goorhuis; Davidson H Hamer; Mirjam Schunk; Sabine Jordan; Frank P Mockenhaupt; François Chappuis; Hilmir Asgeirsson; Eric Caumes; Mogens Jensenius; Perry J J van Genderen; Francesco Castelli; Rogelio López-Velez; Vanessa Field; Emmanuel Bottieau; Israel Molina; Christophe Rapp; Marta Díaz Ménendez; Effrossyni Gkrania-Klotsas; Carsten S Larsen; Denis Malvy; David Lalloo; Federico Gobbi; Simin A Florescu; Philippe Gautret; Patricia Schlagenhauf
Journal:  Lancet Reg Health Eur       Date:  2020-11-12

2.  Evaluation of Vaccination Strategy Against Rabies in Hong Kong Macaques.

Authors:  Paolo Martelli; Sophie St-Hilaire; Wai-Suk Hui; Karthiyani Krishnasamy; Ioannis Magouras; Omid Nekouei
Journal:  Front Vet Sci       Date:  2022-03-21

3.  The shift in rabies epidemiology in France: time to adjust rabies post-exposure risk assessment.

Authors:  Perrine Parize; Laurent Dacheux; Florence Larrous; Hervé Bourhy
Journal:  Euro Surveill       Date:  2018-09

4.  High Diversity and Novel Enteric Viruses in Fecal Viromes of Healthy Wild and Captive Thai Cynomolgus Macaques (Macaca fascicularis).

Authors:  Vorthon Sawaswong; Elizabeth Fahsbender; Eda Altan; Taratorn Kemthong; Xutao Deng; Suchinda Malaivijitnond; Sunchai Payungporn; Eric Delwart
Journal:  Viruses       Date:  2019-10-22       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.